TAF9 anticorps (N-Term)
Aperçu rapide pour TAF9 anticorps (N-Term) (ABIN7188511)
Antigène
Voir toutes TAF9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Humain, Souris, Rat
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogène
- Synthesized peptide derived from the N-terminal region of Human AK6.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB:1:500-1:2000, IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:20000,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- TAF9 (RNA Polymerase II TBP-Associated Factor Subunit G (TAF9))
-
Autre désignation
- AK6
-
Sujet
- AD-004 antibody, Adenylate kinase isoenzyme 6 antibody, Adrenal gland protein AD-004 antibody, AK/ATPase antibody, AK6 antibody, CGI-137 antibody, CIP antibody, Coilin-interacting nuclear ATPase protein antibody, Dual activity adenylate kinase/ATPase antibody, hCINAP antibody, KAD6_HUMAN antibody, TAF9 antibody
-
UniProt
- Q9Y3D8
-
Pathways
- Negative Regulation of intrinsic apoptotic Signaling
Antigène
-